Literature DB >> 20691799

Regulatory T cell content in the bone marrow graft does not predict the occurrence of acute GVHD.

Michelle Rosenzwajg1, Nathalie Dhédin, Sébastien Maury, Gilbert Bensimon, Dan Avi Landau, Françoise Norol, Hélène Trébéden-Negre, Madalina Uzunov, Jean-Paul Vernant, David Klatzmann, José L Cohen.   

Abstract

The subpopulation of regulatory T cells (Treg) was shown to play a key role in alloreactive responses. In allogeneic hematopoietic stem cell transplantation, several groups tested whether Treg content in transplants correlates with graft-versus-host disease (GVHD) with controversial results. In a retrospective study of 49 consecutive HLA-matched sibling transplantations, we studied the relationship between Treg content in bone marrow transplants and acute GVHD (aGVHD) occurrence. We observed a large variability in Treg in bone marrow grafts. However, contrary to previous observations in peripheral blood stem cells transplantation, we report that the Treg content of allogeneic bone marrow transplantation did not predict the occurrence of aGVHD.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691799     DOI: 10.1016/j.bbmt.2010.07.024

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  7 in total

Review 1.  Regulatory T cells in acute myelogenous leukemia: is it time for immunomodulation?

Authors:  Celalettin Ustun; Jeffrey S Miller; David H Munn; Daniel J Weisdorf; Bruce R Blazar
Journal:  Blood       Date:  2011-08-31       Impact factor: 22.113

Review 2.  Tregs: hype or hope for allogeneic hematopoietic stem cell transplantation?

Authors:  F Lussana; M Di Ianni; A Rambaldi
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

3.  Pre-transplant donor CD4- invariant NKT cell expansion capacity predicts the occurrence of acute graft-versus-host disease.

Authors:  M-T Rubio; M Bouillié; N Bouazza; T Coman; H Trebeden-Nègre; A Gomez; F Suarez; D Sibon; A Brignier; E Paubelle; S Nguyen-Khoc; M Cavazzana; O Lantz; M Mohty; S Urien; O Hermine
Journal:  Leukemia       Date:  2016-10-14       Impact factor: 11.528

4.  A distinct glycerophospholipid metabolism signature of acute graft versus host disease with predictive value.

Authors:  Yue Liu; Aijie Huang; Qi Chen; Xiaofei Chen; Yang Fei; Xiaoming Zhao; Weiping Zhang; Zhanying Hong; Zhenyu Zhu; Jianmin Yang; Yifeng Chai; Jianmin Wang; Xiaoxia Hu
Journal:  JCI Insight       Date:  2019-07-25

5.  Circulating CD14(+) HLA-DR(-/low) myeloid-derived suppressor cells in leukemia patients with allogeneic hematopoietic stem cell transplantation: novel clinical potential strategies for the prevention and cellular therapy of graft-versus-host disease.

Authors:  Jin Yin; Chunyan Wang; Min Huang; Xia Mao; Jianfeng Zhou; Yicheng Zhang
Journal:  Cancer Med       Date:  2016-04-25       Impact factor: 4.452

6.  CD4+CD8+ T-Lymphocytes in Xenogeneic and Human Graft-versus-Host Disease.

Authors:  Kutaiba Alhaj Hussen; David Michonneau; Vincent Biajoux; Seydou Keita; Laetitia Dubouchet; Elisabeth Nelson; Niclas Setterblad; Helene Le Buanec; Jean-David Bouaziz; Fabien Guimiot; Gérard Socié; Bruno Canque
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

7.  High preharvest donor Foxp3 mRNA level predicts late relapse of acute lymphoblastic leukaemia after haematopoietic stem cell transplantation.

Authors:  Niels Jacobsen; Tina Frisch; Niels Keiding; Carsten Heilmann; Henrik Sengeløv; Hans O Madsen; Hanne Marquart; Ebbe Dickmeiss; Mette K Andersen; Claus B Christiansen; Lars P Ryder
Journal:  Eur J Haematol       Date:  2021-02-15       Impact factor: 2.997

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.